UK: +44 1379 658 721
Ireland: +353 89 221 3723
USA: +1 754 252 3536
Middle East - N. Africa: + 971 52 873 4738
Australia: +61 3 9310 5259
The UK’s government is the first in the world to temporarily authorise the Pfizer-BioNTech vaccine for emergency use. It has pre-ordered 40 million doses, enough for 20 million of our most at-risk people.
The two-shot vaccine will be distributed from this week onwards, in special cardboard boxes packed with dry ice so it stays at the required temperature of minus 70. Once delivered they can be stashed in an ordinary fridge for as long as 5 days.
The Joint Committee on Vaccinations and Immunisations recommends priority is given to care home residents and their carers, followed by front-line health and social care workers, and those over aged 80. Following that we’ll see people of 75 or over getting their vaccinations, plus those who are ‘clinically extremely vulnerable’. Pregnant women and most children under 16 won’t get it, simply because there’s no vaccine safety data for those groups. As you can imagine, we can’t go around testing vaccines willy nilly on children and pregnant women!
UK government accepts MHRA advice
The Government accepted the recommendation of the independent Medicines and Healthcare products Regulatory Agency (MHRA) when approving the vaccine. Approval comes thanks to months of rigorous clinical trials and a very thorough analysis of the data by experts at the MHRA. They say the vaccine has met all the relevant standards of safety, quality and effectiveness thanks to a process called a ‘rolling review’, which cuts no corners.
The data has also been studied by the independent advisory body, the UK Commission on Human Medicines. They used a ‘wide range of experts’ working with unprecedented amounts of raw data to come to their conclusion, which examined the vaccine’s safety as well as its effectiveness.
The most important thing right now is patience. The vaccine will take months to roll out to the entire population and in the meantime we’ll probably still be battling spikes, surges and outbreaks. If enough people refuse the vaccine it won’t do the job properly, so ‘vaccine hesitancy’ is a big worry.
What’s happening with vaccines elsewhere?
Other EU countries can legally follow the UK in approving a vaccine for emergency use before the EMA gives its own go-ahead, but the European Commission is encouraging other nations to wait for the EMA’s stamp of approval.
The Russian leader Vladimir Putin has ordered Russian authorities to begin mass voluntary vaccinations using their Sputnik V vaccine next week. They’ll have two million doses of the two-dose injection ready. China says it’ll have 600 million doses of vaccine ready this year, and they’re going to make a major announcement about it soon.
Meanwhile, in the USA, the Centres for Disease Control and Prevention panel is giving advice about who should get a priority vaccine. Public health officials say healthcare workers should be first in line followed by the elderly, other vulnerable groups, and essential workers. Each state will decide how they want to distribute the vaccine, and everyone’s hoping the programme can begin before Christmas. Both the Pfizer-BioNTech and Moderna vaccines are both being reviewed by the FDA for emergency use.
Stay safe, keep customers safe, disinfect with UVC
Going forward, we’ll have to be vigilant for years to come. We’re likely to see outbreaks and spikes in future, and we’ll maybe even need to bring in short, strict local lockdowns to keep the virus under control for good. Future-proof your business with our UVC machines, keep people safe, enjoy a level of certainty.
Last but not least, in a world where US-style litigation is never far away, it makes financial sense to keep your employees, customers and everyone else to visits your premises safe. We’ll take a look at the future legal implications of Covid next time.